Syndax Pharmaceuticals (SNDX) Debt to Equity Ratio: 39.03

Syndax Pharmaceuticals, Inc. (SNDX)

12.90 -0.75 (-5.49%) USD | NASDAQ | Oct 16, 16:00

13.05 +0.15 (+1.16%) After-Hours: 20:00

Debt to Equity Ratio Chart

Historical Debt to Equity Ratio Data

View and export this data back to 2013. Start Trial.

Date	Value
June 30, 2026	39.03
March 31, 2026	8.298
December 31, 2025	5.345
September 30, 2025	2.993
June 30, 2025	2.195
March 31, 2025	1.607
December 31, 2024	1.20
September 30, 2024	0.0023
June 30, 2024	0.0026
March 31, 2024	0.0028
December 31, 2023	0.003
September 30, 2023	0.0052
June 30, 2023	0.0052
March 31, 2023	0.0024
December 31, 2022	0.0025
September 30, 2022	0.0037
June 30, 2022	0.0583
March 31, 2022	0.0561
December 31, 2021	0.0513
September 30, 2021	0.1088
June 30, 2021	0.0968
March 31, 2021	0.091
December 31, 2020	0.0814
September 30, 2020	0.1557

Date	Value
June 30, 2020	0.1393
March 31, 2020	0.3846
December 31, 2019	0.0284
September 30, 2019	0.0228
June 30, 2019	0.0227
March 31, 2019	0.0197
December 31, 2018	0.00
September 30, 2018	0.00
June 30, 2018	0.00
March 31, 2018	0.00
December 31, 2017	0.00
September 30, 2017	0.00
June 30, 2017	0.00
March 31, 2017	0.00
December 31, 2016	0.00
September 30, 2016	0.00
June 30, 2016	0.00
March 31, 2016	0.00
September 30, 2014	-3.808
June 30, 2014	0.00
March 31, 2014	0.00
December 31, 2013	0.00
September 30, 2013	-1.692

Debt to Equity Ratio Definition

The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.

Read full definition.

Debt to Equity Ratio Range, Past 5 Years

View Debt to Equity Ratio Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

Debt to Equity Ratio Benchmarks

View Debt to Equity Ratio Benchmarks